Wednesday, September 16, 2026Latest filing Sep 14, 2026

Jennifer McClellan Periodic Transaction Report

Filed Apr 16, 2026 · House Clerk · 1 transaction

U.S. Representative · D · VA-04 · All trades by Jennifer McClellan

On April 16, 2026, Rep. Jennifer McClellan (D-VA-04) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 sale) dated Apr 7, 2026.

The filing covers 1 ticker, including $VZ.

Reported amount ranges sum to $100K–$250K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 9 days.

Source document: House Clerk filing 20034311

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Jennifer McClellan · Sold $VZ · Apr 7 · $100K–$250K

0.56MED
Disclosure speedx 0.250.60
Trade sizex 0.250.75
Cluster activityx 0.150.30

1 other member traded this name in the same window.

Track recordx 0.35default0.50

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Jennifer McClellan

Get an email the moment Jennifer McClellan files the next one. Free, no card, no spam.

Follow free →
1
Transactions
0 / 1
Buys / sells
1
Tickers
9d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Apr 7, 2026VZVerizon Communications Inc. Common Stock (VZ) [ST]sell$100K–$250K9d

Other recent filings by Jennifer McClellan

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →